Skip to main content

Incyte company profile

  • INCY · Nasdaq
  • Biotechnology
  • S&P 500
$120.97−0.60%Close 13 Nov 2026 · Market value $24.66B

About Incyte

Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.

Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity.

From Wikipedia, shared under CC BY-SA.

Company facts

TickerINCY · Nasdaq
SectorBiotechnology
IndustryBiotechnology
IndexS&P 500
Fiscal year ends31 December
Reporting currencyUSD
CIK879169

Officers and directors

NameRoleShares ownedLatest Form 4
Steven H. SteinCMO &amp; Head of Late-Stage Dev.313K · < 1%Option exercise, 6 Nov 2026
Paul J. ClancyDirector142K · < 1%Grant or award, 30 Sep 2026
Jacqualyn A. FouseDirector141K · < 1%Grant or award, 8 Jun 2026
Edmund P. HarriganDirector86.2K · < 1%Grant or award, 30 Sep 2026
Pablo J. CagnoniPresident, Global Head of R&amp;D84.6K · < 1%Option exercise, 15 Oct 2026
Katherine A. HighDirector75.3K · < 1%Grant or award, 8 Jun 2026
Thomas TrayPrincipal Accounting Officer70.9K · < 1%Sale under a 10b5-1 plan, 3 Nov 2026
Otis W. BrawleyDirector59.3K · < 1%Grant or award, 8 Jun 2026
Christiana StamoulisEVP & Chief Financial Officer57.5K · < 1%Shares withheld for tax, 15 Jul 2025
Susanne SchaffertDirector47.2K · < 1%Grant or award, 10 Jun 2025
Heeson LeeEVP, Head of Incyte Intl—Shares withheld for tax, 1 Oct 2026
BAKER BROS. ADVISORS LPDirector · 10% owner—Grant or award, 30 Sep 2026
Gardner David HEVP, Chief Strategy Officer—Shares withheld for tax, 22 Sep 2026
Basi Ramitpal KEVP, Human Resources—Shares withheld for tax, 25 Aug 2026
Mayes Patrick AEVP & Chief Scientific Officer—Sale under a 10b5-1 plan, 5 Aug 2026
William J. MeuryChief Executive Officer · Director—Grant or award, 16 Jul 2026
Mohamed IssaEVP, Head of U.S. Commercial—Grant or award, 16 Jul 2026
Hoffman Richard A.EVP & General Counsel—Grant or award, 16 Jul 2026
BAKER FELIXDirector · 10% owner—Grant or award, 30 Jun 2026
BIENAIME JEAN JACQUESDirector—Grant or award, 8 Jun 2026

Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.

INCY in the terminal

The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.